Proteins > 5-hydroxytryptamine receptor 1B
Page last updated: 2024-08-07 16:20:23
5-hydroxytryptamine receptor 1B
A 5-hydroxytryptamine receptor 1B that is encoded in the genome of human. [PRO:WCB, UniProtKB:P28222]
Synonyms
5-HT-1B;
5-HT1B;
S12;
Serotonin 1D beta receptor;
5-HT-1D-beta;
Serotonin receptor 1B
Research
Bioassay Publications (72)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 1 (1.39) | 18.7374 |
1990's | 22 (30.56) | 18.2507 |
2000's | 33 (45.83) | 29.6817 |
2010's | 11 (15.28) | 24.3611 |
2020's | 5 (6.94) | 2.80 |
Compounds (66)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
tryptamine | Homo sapiens (human) | Ki | 0.0360 | 1 | 1 |
8-hydroxy-2-(di-n-propylamino)tetralin | Homo sapiens (human) | Ki | 0.5985 | 2 | 2 |
1-(1-naphthyl)piperazine | Homo sapiens (human) | Ki | 0.0104 | 2 | 2 |
5-(nonyloxy)tryptamine | Homo sapiens (human) | Ki | 0.0012 | 1 | 1 |
5-carboxamidotryptamine | Homo sapiens (human) | Ki | 0.0013 | 1 | 1 |
methylbufotenin | Homo sapiens (human) | IC50 | 0.5500 | 1 | 1 |
5-methoxytryptamine | Homo sapiens (human) | Ki | 0.0035 | 1 | 1 |
alpha-methylserotonin | Homo sapiens (human) | Ki | 0.2500 | 1 | 1 |
ketanserin | Homo sapiens (human) | IC50 | 8.2500 | 2 | 2 |
naratriptan | Homo sapiens (human) | Ki | 0.0033 | 1 | 1 |
oxymetazoline | Homo sapiens (human) | Ki | 0.0003 | 1 | 1 |
4-iodoclonidine | Homo sapiens (human) | Ki | 1.9800 | 1 | 1 |
pindolol | Homo sapiens (human) | Ki | 6.3000 | 1 | 2 |
prazosin | Homo sapiens (human) | Ki | 7.7000 | 1 | 1 |
propranolol | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
propranolol | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
rizatriptan | Homo sapiens (human) | IC50 | 0.0410 | 1 | 1 |
rizatriptan | Homo sapiens (human) | Ki | 0.0101 | 1 | 1 |
sumatriptan | Homo sapiens (human) | IC50 | 0.0131 | 7 | 7 |
sumatriptan | Homo sapiens (human) | Ki | 0.0188 | 13 | 13 |
tolazoline | Homo sapiens (human) | Ki | 10.0000 | 2 | 2 |
n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-(2-pyridinyl)cyclohexanecarboxamide | Homo sapiens (human) | Ki | 0.0240 | 1 | 1 |
xylometazoline | Homo sapiens (human) | Ki | 0.0135 | 2 | 2 |
ergotamine | Homo sapiens (human) | Ki | 0.0027 | 2 | 3 |
indopan | Homo sapiens (human) | Ki | 0.5301 | 1 | 2 |
sertindole | Homo sapiens (human) | Ki | 0.0560 | 1 | 1 |
zolmitriptan | Homo sapiens (human) | IC50 | 0.0062 | 1 | 1 |
zolmitriptan | Homo sapiens (human) | Ki | 0.0042 | 1 | 1 |
frovatriptan | Homo sapiens (human) | Ki | 0.0103 | 1 | 1 |
xylonidine | Homo sapiens (human) | Ki | 30.0000 | 1 | 1 |
gr 127935 | Homo sapiens (human) | Ki | 0.0018 | 3 | 3 |
pramipexole | Homo sapiens (human) | Ki | 3.5080 | 1 | 1 |
gr 55562 | Homo sapiens (human) | Ki | 0.0130 | 2 | 2 |
cp 122288 | Homo sapiens (human) | IC50 | 0.0144 | 1 | 1 |
harmalan | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
8-(di-n-propylamino)-6,7,8,9-tetrahydro-3h-benz(e)indole-1-carbaldehyde | Homo sapiens (human) | Ki | 0.3640 | 1 | 1 |
nantenine, (+-)-isomer | Homo sapiens (human) | Ki | 0.1000 | 2 | 2 |
rs 127445 | Homo sapiens (human) | Ki | 0.0003 | 1 | 1 |
1-methyl-6-methoxy-dihydro-beta-carboline | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
sb-224289 | Homo sapiens (human) | Ki | 0.0082 | 2 | 2 |
harmine | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
ly 344864 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
l 745870 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
ly 334370 | Homo sapiens (human) | Ki | 0.1877 | 3 | 3 |
sb 258719 | Homo sapiens (human) | Ki | 5.0119 | 1 | 1 |
sb 271046 | Homo sapiens (human) | Ki | 0.7943 | 1 | 1 |
gr 46611 | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine | Homo sapiens (human) | IC50 | 0.0735 | 4 | 4 |
sb 269970 | Homo sapiens (human) | Ki | 5.5000 | 2 | 2 |
ms-245 | Homo sapiens (human) | Ki | 5.7050 | 2 | 2 |
n-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide | Homo sapiens (human) | Ki | 3.9811 | 1 | 1 |
l 772405 | Homo sapiens (human) | IC50 | 0.1675 | 2 | 2 |
sb258741 | Homo sapiens (human) | Ki | 1.5849 | 1 | 1 |
5-chloro-2,3-dihydro-6-(4-methylpiperazin-1-yl)-1-(4-(pyridin-4-yl)naphth-1-ylaminocarbonyl)-1h-indole | Homo sapiens (human) | Ki | 0.0060 | 2 | 2 |
pnu 109291 | Homo sapiens (human) | Ki | 5.7750 | 1 | 1 |
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
sb-656104-a | Homo sapiens (human) | Ki | 0.6310 | 1 | 1 |
5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
sb-649915 | Homo sapiens (human) | Ki | 0.0100 | 5 | 5 |
sb 328437 | Homo sapiens (human) | IC50 | 0.0070 | 1 | 1 |
naphyrone | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
col-144 | Homo sapiens (human) | Ki | 0.5910 | 1 | 1 |
a 803467 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
sp 203 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
n,n-diallyl-5-methoxytryptamine | Homo sapiens (human) | Ki | 0.3330 | 2 | 3 |
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
metergoline | Homo sapiens (human) | Activity | 0.0280 | 1 | 1 |
sb 269970 | Homo sapiens (human) | Kb | 0.0010 | 1 | 1 |
Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 8, Issue:11, 1998
Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.Journal of medicinal chemistry, , Jun-09, Volume: 38, Issue:12, 1995
Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 8, Issue:11, 1998
5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine.Journal of medicinal chemistry, , Nov-21, Volume: 40, Issue:24, 1997
Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin.Journal of medicinal chemistry, , Nov-13, Volume: 35, Issue:23, 1992
Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.Journal of medicinal chemistry, , Volume: 21, Issue:8, 1978
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.Journal of medicinal chemistry, , Dec-02, Volume: 42, Issue:24, 1999
3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.Journal of medicinal chemistry, , Dec-10, Volume: 58, Issue:23, 2015
2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.Journal of medicinal chemistry, , Feb-11, Volume: 42, Issue:3, 1999
3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.Journal of medicinal chemistry, , Jun-26, Volume: 51, Issue:12, 2008
3-(2-pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT(1B/1D) ligands.Bioorganic & medicinal chemistry letters, , Feb-09, Volume: 14, Issue:3, 2004
(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands.Bioorganic & medicinal chemistry letters, , Oct-20, Volume: 13, Issue:20, 2003
Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.Journal of medicinal chemistry, , Mar-01, Volume: 44, Issue:5, 2001
5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.Bioorganic & medicinal chemistry letters, , Aug-07, Volume: 10, Issue:15, 2000
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.Bioorganic & medicinal chemistry letters, , May-01, Volume: 10, Issue:9, 2000
3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.Journal of medicinal chemistry, , Feb-11, Volume: 42, Issue:3, 1999
Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.Journal of medicinal chemistry, , Dec-02, Volume: 42, Issue:24, 1999
Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist.Bioorganic & medicinal chemistry letters, , Mar-17, Volume: 8, Issue:6, 1998
Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
5-HT1D receptor agonist properties of novel 2-[5-[[(trifluoromethyl)sulfonyl]oxy]indolyl]ethylamines and their use as synthetic intermediates.Journal of medicinal chemistry, , Nov-22, Volume: 39, Issue:24, 1996
Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists.Journal of medicinal chemistry, , Dec-06, Volume: 39, Issue:25, 1996
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.Journal of medicinal chemistry, , Jan-05, Volume: 39, Issue:1, 1996
Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors.Journal of medicinal chemistry, , Sep-01, Volume: 38, Issue:18, 1995
5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist.Journal of medicinal chemistry, , Sep-02, Volume: 37, Issue:18, 1994
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.Bioorganic & medicinal chemistry letters, , Sep-20, Volume: 14, Issue:18, 2004
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.Journal of medicinal chemistry, , Jun-18, Volume: 41, Issue:13, 1998
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.Bioorganic & medicinal chemistry letters, , Sep-20, Volume: 14, Issue:18, 2004
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.Journal of medicinal chemistry, , Jun-18, Volume: 41, Issue:13, 1998
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 24, Issue:2, 2014
A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 21, Issue:22, 2011
Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.Journal of medicinal chemistry, , Mar-01, Volume: 44, Issue:5, 2001
Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist.Bioorganic & medicinal chemistry letters, , Mar-17, Volume: 8, Issue:6, 1998
Synthesis of potent and selective serotonin 5-HT1B receptor ligands.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 15, Issue:21, 2005
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function bJournal of medicinal chemistry, , Apr-09, Volume: 41, Issue:8, 1998
C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 25, Issue:17, 2015
Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Synthesis of potent and selective serotonin 5-HT1B receptor ligands.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 15, Issue:21, 2005
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function bJournal of medicinal chemistry, , Apr-09, Volume: 41, Issue:8, 1998
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.Journal of medicinal chemistry, , Jun-26, Volume: 51, Issue:12, 2008
Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.Bioorganic & medicinal chemistry letters, , Dec-20, Volume: 14, Issue:24, 2004
Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.Journal of medicinal chemistry, , Jul-03, Volume: 46, Issue:14, 2003
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.Journal of medicinal chemistry, , Jun-17, Volume: 42, Issue:12, 1999
3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
Discovery of G Protein-Biased Antagonists against 5-HTJournal of medicinal chemistry, , 09-23, Volume: 64, Issue:18, 2021
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 25, Issue:7, 2015
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.Journal of medicinal chemistry, , Nov-08, Volume: 44, Issue:23, 2001
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.Bioorganic & medicinal chemistry letters, , Oct-16, Volume: 10, Issue:20, 2000
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.Journal of medicinal chemistry, , Dec-02, Volume: 42, Issue:24, 1999
3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.Journal of medicinal chemistry, , Oct-24, Volume: 40, Issue:22, 1997
Identification of a potent and selective 5-HT1B receptor antagonist.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 15, Issue:21, 2005
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 15, Issue:19, 2005
Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 18, Issue:20, 2008
Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.Journal of medicinal chemistry, , May-22, Volume: 51, Issue:10, 2008
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 17, Issue:4, 2007
Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 17, Issue:18, 2007
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.Journal of medicinal chemistry, , May-19, Volume: 48, Issue:10, 2005
Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 26, Issue:3, 2016
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 23, Issue:11, 2013
Enables
This protein enables 5 target(s):
Target | Category | Definition |
G protein-coupled serotonin receptor activity | molecular function | Combining with the biogenic amine serotonin and transmitting the signal across the membrane by activating an associated G-protein. Serotonin (5-hydroxytryptamine) is a neurotransmitter and hormone found in vertebrates and invertebrates. [GOC:ai] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
serotonin binding | molecular function | Binding to serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties. [GOC:ai] |
voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | molecular function | Regulation of presynaptic cytosolic calcium ion concentrations via the action of voltage-gated calcium ion channels. [GOC:dos, PMID:15548655] |
neurotransmitter receptor activity | molecular function | Combining with a neurotransmitter and transmitting the signal to initiate a change in cell activity. [GOC:jl, GOC:signaling] |
Located In
This protein is located in 5 target(s):
Target | Category | Definition |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
presynaptic membrane | cellular component | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. [GOC:jl, ISBN:0815316194] |
calyx of Held | cellular component | The terminal specialization of a calyciferous axon which forms large synapses in the mammalian auditory central nervous system. [NIF_Subcellular:sao1684283879, PMID:11823805] |
serotonergic synapse | cellular component | A synapse that uses serotonin as a neurotransmitter. [GOC:dos] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
dendrite | cellular component | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. [GOC:aruk, GOC:bc, GOC:dos, GOC:mah, GOC:nln, ISBN:0198506732] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
G protein-coupled serotonin receptor complex | cellular component | A protein complex that is capable of G protein-coupled serotonin receptor activity. [GO_REF:0000088, GOC:bhm, GOC:TermGenie] |
Involved In
This protein is involved in 25 target(s):
Target | Category | Definition |
G protein-coupled receptor internalization | biological process | The process that results in the uptake of a G protein-coupled receptor into an endocytic vesicle. [PMID:8396717] |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the inhibition of adenylyl cyclase activity and a subsequent decrease in the intracellular concentration of cyclic AMP (cAMP). [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
adenylate cyclase-inhibiting serotonin receptor signaling pathway | biological process | An adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway initiated by serotonin binding to its receptor, and ending with the regulation of a downstream cellular process. [GOC:dph, GOC:mah, GOC:signaling, GOC:tb] |
protein kinase C-activating G protein-coupled receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of protein kinase C (PKC). PKC is activated by second messengers including diacylglycerol (DAG). [GOC:mah, GOC:signaling] |
negative regulation of gamma-aminobutyric acid secretion | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of gamma-aminobutyric acid. [GOC:ef] |
regulation of dopamine secretion | biological process | Any process that modulates the frequency, rate or extent of the regulated release of dopamine. [GOC:ef] |
negative regulation of serotonin secretion | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin. [GOC:ef] |
negative regulation of synaptic transmission, GABAergic | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). [GOC:mah] |
response to cocaine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant. [GOC:ef, GOC:jl] |
vasoconstriction | biological process | A decrease in the diameter of blood vessels, especially arteries, due to constriction of smooth muscle cells that line the vessels, and usually causing an increase in blood pressure. [GOC:pr, ISBN:0192800752] |
drinking behavior | biological process | The specific behavior of an organism relating to the intake of liquids, especially water. [GOC:curators, GOC:pr] |
response to ethanol | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. [GOC:go_curators] |
bone remodeling | biological process | The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis. [GOC:curators] |
regulation of behavior | biological process | Any process that modulates the frequency, rate or extent of behavior, the internally coordinated responses (actions or inactions) of whole living organisms (individuals or groups) to internal or external stimuli. [GOC:go_curators, GOC:pr] |
response to mineralocorticoid | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone. Mineralocorticoids act primarily on water and electrolyte balance. [GOC:ai, PMID:9884123] |
negative regulation of synaptic transmission, glutamatergic | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. [GOC:ai] |
cellular response to alkaloid | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active. [GOC:mah] |
cellular response to xenobiotic stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:krc, GOC:mah] |
cellular response to temperature stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus. [GOC:mah] |
presynaptic modulation of chemical synaptic transmission | biological process | Any process, acting in the presynapse that results in modulation of chemical synaptic transmission. [GOC:dos] |
regulation of presynaptic cytosolic calcium ion concentration | biological process | Any process that regulates the concentration of calcium in the presynaptic cytosol. [GOC:dos] |
positive regulation of vascular associated smooth muscle cell proliferation | biological process | Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation. [GO_REF:0000058, GOC:TermGenie, PMID:23246467] |
regulation of synaptic vesicle exocytosis | biological process | Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis. [GOC:obol] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. [GOC:mah, GOC:signaling, ISBN:0815316194] |